« Back to Record
Schröder, F., Whelan, P., De Reijke, T. M., Kurth, K., Pavone-Macaluso, M., Mattelaer, J., Van Velthoven, R., Debois, M., Collette, L., & Members of the EORTC Genito-Urinary Group, (2004). Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. European urology, 45(4), 457-464. doi:10.1016/j.eururo.2003.11.016
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/124557



